Sageworth Trust’s Novartis NVS Stock Holding History

Sageworth Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,310	Closed	-$424K	–	229
2025 Q3	$424K	Buy	+3,310	New	+$404K	0.02%	173
2023 Q2	–	Sell	-500	Closed	-$46K	–	322
2023 Q1	$46K	Hold	500	–	–	﹤0.01%	143
2022 Q4	$45K	Hold	500	–	–	﹤0.01%	129
2022 Q3	$38K	Hold	500	–	–	﹤0.01%	128
2022 Q2	$42K	Hold	500	–	–	﹤0.01%	162
2022 Q1	$44K	Hold	500	–	–	﹤0.01%	103
2021 Q4	$44K	Hold	500	–	–	﹤0.01%	112
2021 Q3	$41K	Sell	500 -25	-5%	-$2.25K	﹤0.01%	214
2021 Q2	$48K	Hold	525	–	–	﹤0.01%	235
2021 Q1	$45K	Hold	525	–	–	﹤0.01%	183
2020 Q4	$50K	Hold	525	–	–	﹤0.01%	118
2020 Q3	$46K	Hold	525	–	–	0.01%	86
2020 Q2	$46K	Hold	525	–	–	0.01%	77
2020 Q1	$43K	Hold	525	–	–	0.01%	81
2019 Q4	$50K	Buy	525 +25	+5%	+$2.24K	0.01%	90
2019 Q3	$43K	Hold	500	–	–	0.01%	99
2019 Q2	$46K	Sell	500 -58	-10%	-$4.91K	0.01%	94
2019 Q1	$48K	Hold	558	–	–	0.01%	84
2018 Q4	$43K	Hold	558	–	–	0.01%	82
2018 Q3	$43K	Hold	558	–	–	0.01%	100
2018 Q2	$38K	Hold	558	–	–	0.01%	53
2018 Q1	$40K	Hold	558	–	–	0.01%	37
2017 Q4	$42K	Hold	558	–	–	0.01%	38
2017 Q3	$43K	Hold	558	–	–	0.01%	37
2017 Q2	$42K	Buy	558 +112	+25%	+$7.94K	0.01%	79
2017 Q1	$30K	Hold	446	–	–	0.01%	53
2016 Q4	$29K	Buy	+446	New	+$28.9K	0.01%	43

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sageworth Trust's NVS Position: Q4 2025 in Review

Sageworth Trust sold out of Novartis (NVS) in Q4 2025, closing a stake of 3,310 shares — an estimated $424K sold.

Sageworth Trust first reported a position in NVS in Q4 2016 and held it in 27 quarters. The position peaked at $424K in Q3 2025. 1,509 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

Sageworth Trust reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
Sageworth Trust sold 3,310 Novartis shares in Q4 2025, an estimated $424K.
Sageworth Trust first reported a position in Novartis in Q4 2016 and held it in 27 quarters.
Sageworth Trust's Novartis position peaked at $424K in Q3 2025.
1,509 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Sageworth Trust's 13F filing for Q4 2025, filed 3 Feb 2026.